GDNF: A novel factor with therapeutic potential for neurodegenerative disorders

Molecular Neurobiology

Volumn 19, Issue 1, 1999, Pages 43-59

  Walton, Kevin M ^a  

^a CEPHALON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LIGAND; PROTEIN TYROSINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL POPULATION; CELL SURVIVAL; DOPAMINERGIC SYSTEM; LIGAND BINDING; MONKEY; NERVE DEGENERATION; NERVE TRANSECTION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FAMILY; RECEPTOR BINDING; TISSUE DISTRIBUTION;

EID: 0032965386     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02741377     Document Type: Article

References (95)

1. Lin, L.-F., Doherty, D. H., Lile, J. D., Bektesh, S. and Collins, F. (1993) GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260, 1130-1132.
2. McDonald, N. Q. and Hendrickson, W. A. (1993) A structural superfamily of growth factors containing a cystine knot motif. Cell 73, 421-424.
3. Kingsley, D. M. (1994) The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8, 133-146.
4. Santoro, M., Carlomagno, F., Hay, I. D., Herrmann, M. A., Grieco, M., Melillo, R., Pierotti, M. A., Bongarzone, I., Della Porta, G., Berger, N., et al. (1992) Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J. Clin. Invest. 89, 1517-1522.
5. Mulligan, L. M., Kwok, J. B., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S., Moore, J. K., Papi, L., et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363, 458-460.
6. Donis-Keller, H., Dou, S., Chi, D., Carlson, K. M., Toshima, K., Lairmore, T. C., Howe, J. R., Moley, J. F., Goodfellow, P. and Wells, S. A. J. (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum. Mol. Genet. 2, 851-856.
7. Carlson, K. M., Dou, S., Chi, D., Scavarda, N., Toshima, K., Jackson, C. E., Wells, S. A. J., Goodfellow, P. J. and Donis-Keller, H. (1994) Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. Proc. Natl. Acad. Sci. USA 91, 1579-1583.
8. Carlomagno, F., De Vita, G., Berlingieri, M. T., De Franciscis, V., Melillo, R. M., Colantuoni, V., Kraus, M. H., Di Fiore, P. P., Fusco, A. and Santoro, M. (1996) Molecular heterogeneity of RET loss of function in Hirschsprung's disease. EMBO J. 15, 2717-2725.
9. Edery, P., Lyonnet, S., Mulligan, L. M., Pelet, A., Dow, E., Abel, L., Holder, S., Nihoul-Fekete, C., Ponder, B. A. and Munnich, A. (1994) Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature 367, 378-380.
10. Romeo, G., Ronchetto, P., Luo, Y., Barone, V., Seri, M., Ceccherini, I., Pasini, B., Bocciardi, R., Lerone, M. and Kaariainen, H. (1994) Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 367, 377-378.
11. Rescorla, F. J., Morrison, A. M., Engles, D., West, K. W. and Grosfeld, J. L. (1992) Hirschsprung's disease. Evaluation of mortality and long-term function in 260 cases. Arch. Surg. 127, 934-941.
12. Schuchardt, A., D'Agati, V., Larsson-Blomberg, L., Costantini, F. and Pachnis, V. (1994) Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367, 380-383.
13. Pachnis, V., Mankoo, B. and Costantini, F. (1993) Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119, 1005-1017.
14. Saxen L. (1987) Organogenesis of the Kidney. Cambridge University Press, Cambridge, UK.
15. Lechner, M. S. and Dressler, G. R. (1997) The molecular basis of embryonic kidney development. Mech. Dev. 62, 105-120.
16. Sariola, H. and Sainio, K. (1997) The tip-top branching ureter. Curr. Opin. Cell. Biol. 9, 877-884.
17. Kearns, C. M. and Gash, D. M. (1995) GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672, 104-111.
18. Li, L., Wu, W., Lin, L.-F., Lei, M., Oppenheim, R. W. and Houenou, L. J. (1995) Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA 92, 9771-9775.
19. Henderson, C. E., Phillips, H. S., Pollock, R. A., Davies, A. M., Lemeulle, C., Armanini, M., Simpson, L. C., Moffet, B., Vandlen, R. A., Koliatsos, V. E., et al. (1994) GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266, 1062-1064.
20. Beck, K. D., Valverde, J., Alexi, T., Poulsen, K., Moffat, B., Vandlen, R. A., Rosenthal, A. and Hefti, F. (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373, 339-341.
21. Oppenheim, R. W., Houenou, L. J., Johnson, J. E., Lin, L.-F. H., Li, L., Lo, A. C., Newsome, A. L., Prevette, D. M. and Wang, S. (1995) Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 373, 344-346.
22. Yan, Q., Matheson, C. and Lopez, O. T. (1995) In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 373, 341-344.
23. Zurn, A. D., Winkel, L., Menoud, A., Djabali, K. and Aebischer, P. (1996) Combined effects of GDNF, BDNF, and CNTF on motoneuron differentiation in vitro. J. Neurosci. Res. 44, 133-141.
24. Gash, D. M., Zhang, Z. M., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P. A., Collins, F., et al. (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380, 252-255.
25. Hoffer, B. J., Hoffman, A., Bowenkamp, K., Huettl, P., Hudson, J., Martin, D., Lin, L. H. and Gerhardt, G. A. (1994) Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182, 107-111.
26. Suvanto, P., Hiltunen, J. O., Arumäe, U., Moshnyakov, M., Sariola, H., Sainio, K. and Saarma, M. (1996) Localization of glial cell line-derived neurotrophic factor (GDNF) mRNA in embryonic rat by in situ hybridization. Eur. J. Neurosci. 8, 816-822.
27. Sánchez, M. P., Silos-Santiago, I., Frisén, J., He, B., Lira, S. A. and Barbacid, M. (1996) Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382, 70-73.
28. Pichel, J. G., Shen, L. Y., Sheng, H. Z., Granholm, A. C., Drago, J., Grinberg, A., Lee, E. J., Huang, S. P., Saarma, M., Hoffer, B. J., et al. (1996) Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382, 73-76.
29. Moore, M. W., Klein, R. D., Fariñas, I., Sauer, H., Armanini, M., Phillips, H., Reichardt, L. F., Ryan, A. M., Carver-Moore, K. and Rosenthal, A. (1996) Renal and neuronal abnormalities in mice lacking GDNF. Nature 382, 76-79.
30. Tomac, A., Lindqvist, E., Lin, L.-F. H., Ögren, S. O., Young, D., Hoffer, B. J. and Olson, L. (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373, 335-339.
31. Arenas, E., Trupp, M., Akerud, P. and Ibáñez, C. F. (1995) GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 15, 1465-1473.
32. Durbec, P., Marcos-Gutierrez, C. V., Kilkenny, C., Grigoriou, M., Wartiovaara, K., Suvanto, P., Smith, D., Ponder, B., Costantini, F., Saarma, M., et al. (1996) GDNF signalling through the Ret receptor tyrosine kinase. Nature 381, 789-793.
33. Trupp, M., Arenas, E., Fainzilber, M., Nilsson, A. S., Sieber, B. A., Grigoriou, M., Kilkenny, C., Salazar-Grueso, E., Pachnis, V., Arumäe, U., et al. (1996) Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381, 785-789.
34. Vega, Q. C., Worby, C. A., Lechner, M. S., Dixon, J. E. and Dressler, G. R. (1996) Glial cell line-derived neurotrophic factor activates the receptor tyrosine kinase RET and promotes kidney morphogenesis. Proc Natl Acad Sci USA 93, 10,657-10,661.
35. Worby, C. A., Vega, Q. C., Zhao, Y., Chao, H. H. J., Seasholtz, A. F. and Dixon, J. E. (1996) Glial cell line-derived neurotrophic factor signals through the RET receptor and activates mitogen-activated protein kinase. J. Biol. Chem. 271, 23,619-23,622.
36. Sainio, K., Suvanto, P., Davies, J., Wartiovaara, J., Wartiovaara, K., Saarma, M., Arumae, U., Meng, X., Lindahl, M., Pachnis, V., et al. (1997) Glial-cell-line-derived neurotrophic factor is required for bud initiation from the ureteric epithelium. Development 124, 4077-4087.
37. Jing, S. Q., Wen, D. Z., Yu, Y. B., Holst, P. L., Luo, Y., Fang, M., Tamir, R., Antonio, L., Hu, Z., Cupples, R., et al. (1996) GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85, 1113-1124.
38. Treanor, J. J. S., Goodman, L., De Sauvage, F., Stone, D. M., Poulsen, K. T., Beck, C. D., Gray, C., Armanini, M. P., Pollock, R. A., Hefti, F., et al. (1996) Characterization of a multicomponent receptor for GDNF. Nature 382, 80-83.
39. Baloh, R. H., Tansey, M. G., Golden, J. P., Creedon, D. J., Heuckeroth, R. O., Keck, C. L., Zimonjic, D. B., Popescu, N. C., Johnson, E. M.J. and Milbrandt, J. (1997) TrnR2, a novel receptor that mediates neurturin and GDNF signaling through Ret. Neuron 18, 793-802.
40. Ip, N. Y. and Yancopoulos, G. D. (1996) The neurotrophins and CNTF: Two families of collaborative neurotrophic factors. Annu. Rev. Neurosci. 19, 491-515.
41. Klein, R. D., Sherman, D. P., Henderson CE, Ho, W. H., Stone, D., Bennett, G. L., Moffat, B., Vandlen, R., Simmons, L., Gu, Q., Hongo, J. A., et al. (1997) A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature 387, 717-721.
42. Kotzbauer, P. T., Lampe, P. A., Heuckeroth, R. O., Golden, J. P., Creedon, D. J., Johnson, E. M. and Milbrandt, J. (1996) Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature 384, 467-470.
43. Milbrandt, J., de Sauvage, F. J., Fahrner, T. J., Baloh, R. H., Leitner, M. L., Tansey, M. G., Lampe, P. A., Heuckeroth, R. O., Kotzbauer, P. T., Simburger, K. S., et al. (1998) Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron 20, 245-253.
44. Enokido, Y., De Sauvage, F., Hongo, J., Ninkina, N., Rosenthal, A., Buchman, V. L., and Davies, A. M. (1998) GFRα-4 and the tyrosine kinase Ret form a functional receptor complex for persephin. Curr. Biol. 8, 1019-1022.
45. Suvanto, P., Wartiovaara, K., Lindahl, M., Arumae, U., Moshnyakov, M., Horelli-Kuitunen, N., Airaksinen, M., Palotie, A., Sariola, H. and Saarma, M. (1997) Cloning, mRNA distribution and chromosomal localisation of the gene for human glial cell line-derived neurotrophic factor receptor beta, a homologue to GDNFR-alpha. Hum. Mol. Genet. 6, 1267-1273.
46. Buj-Bello, A., Adu, J., Pinon, L. G., Horton, A., Thompson, J., Rosenthal, A., Chinchetru, M., Buchman, V. L. and Davies, A. M. (1997) Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase. Nature 387, 721-724.
47. Widenfalk, J., Nosrat, C., Tomac, A., Westphal, H., Hoffer, B. and Olson, L. (1997) Neurturin and glial cell line-derived neurotrophic factor receptor-beta (GDNFR-β), novel proteins related to GDNF and GDNFR-α with specific cellular patterns of expression suggesting roles in the developing and adult nervous system and in peripheral organs. J. Neurosci. 17, 8506-8519.
48. Sanicola, M., Hession, C., Worley, D., Carmillo, P., Ehrenfels, C., Walus, L., Robinson, S., Jaworski, G., Wei, H., Tizard, R., et al. (1997) Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins. Proc. Natl. Acad. Sci. USA 94, 6238-6243.
49. Trupp, M., Raynoschek, C., Belluardo, N. and Ibáñez, C. F. (1998) Multiple GPI-anchored receptors control GDNF-dependent and independent activation of the c-ret receptor tyrosine kinase. Mol. Cell. Neurosci. 11, 47-63.
50. Worby, C. A., Vega, Q. C., Chao, H. H. J., Seasholtz, A. F., Thompson, R. C. and Dixon, J. E. (1998) Identification and characterization of GFRalpha-3, a novel co-receptor belonging to the glial cell line-derived neurotrophic receptor family. J. Biol. Chem. 273, 3502-3508.
51. Jing, S., Yu, Y., Fang, M., Hu, Z., Holst, P. L., Boone, T., Delaney, J., Schultz, H., Zhou, R. and Fox, G. M. (1997) GFRalpha-2 and GFRalpha-3 are two new receptors for ligands of the GDNF family. J. Biol. Chem. 272, 33,111-33,117.
52. Naveilhan, P., Baudet, C., Mikaels, A., Shen, L., Westphal, H. and Ernfors, P. (1998) Expression and regulation of GFRalpha3, a glial cell line-derived neurotrophic factor family receptor. Proc. Natl. Acad. Sci. USA 95, 1295-1300.
53. Thompson, J., Doxakis, E., Pinon, L. G. P., Strachan, P., Buj-Bello, A., Wyatt, S., Buchman, V. L., and Davies, A. M. (1998) GFRα-4, a new GDNF family receptor. Mol Cell Neurol 11, 117-126.
54. Trupp, M., Belluardo, N., Funakoshi, H. and Ibáñez, C. F. (1997) Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS. J. Neurosci. 17, 3554-3567.
55. Trupp, M., Rydén, M., Jörnvall, H., Funakoshi, H., Timmusk, T., Arenas, E. and Ibáñez, C. F. (1995) Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J. Cell. Biol. 130, 137-148.
56. Granholm, A. C. E., Srivastava, N., Mott, J. L., Henry, M., Westphal, H., Pichel, J. G., Shen, L. Y. and Hoffer, B. J. (1997) Morphological alterations in the peripheral and central nervous systems of mice lacking glial cell line-derived neurotrophic factor (GDNF): Immunohistochemical studies. J. Neurosci. 17, 1168-1178.
57. Tsuzuki, T., Takahashi, M., Asai, N., Iwashita, T., Matsuyama, M. and Asai, J. (1995) Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues. Oncogene 10, 191-198.
58. Robertson, K. and Mason, I. (1995) Expression of ret in the chicken embryo suggests roles in regionalisation of the vagal neural tube and somites and in development of multiple neural crest and placodal lineages. Mech. Dev. 53, 329-344.
59. Marcos-Gutiérrez, C. V., Wilson, S. W., Holder, N. and Pachnis, V. (1997) The zebrafish homologue of the ret receptor and its pattern of expression during embryogenesis. Oncogene 14, 879-889.
60. Nosrat, C. A., Tomac, A., Hoffer, B. J. and Olson, L. (1997) Cellular and developmental patterns of expression of Ret and glial cell line-derived neurotrophic factor receptor alpha mRNAs. Exp. Brain Res. 115, 410-422.
61. Ylikoski J, Pirvola U, Virkkala J, et al. (1998) Guinea pig auditory neurons are protected by glial cell line-derived growth factor from degeneration after noise trauma. Hear. Res. 124, 17-26.
62. Naveilhan, P., ElShamy, W. M. and Ernfors, P. (1997) Differential regulation of mRNAs for GDNF and its receptors Ret and GDNFR alpha after sciatic nerve lesion in the mouse. Eur. J. Neurosci. 9, 1450-1460.
63. Nakamura, M., Ohta, K., Hirokawa, K., Fukushima, M., Uchino, M., Ando, M. and Tanaka, H. (1996) Developmental and denervation changes in c-ret proto-oncogene expression in chick motoneurons. Brain Res. Mol. Brain Res. 39, 1-11.
64. Clarkson, E. D., Zawada, W. M. and Freed, C. R. (1995) GDNF reduces apoptosis in dopaminergic neurons in vitro. Neuro Report 7, 145-149.
65. Hou, J. G., Lin, L. f. and Mytilineou, C. (1996) Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium. J. Neurochem. 66, 74-82.
66. Buj-Bello, A., Buchman, V. L., Horton, A., Rosenthal, A. and Davies, A. M. (1995) GDNF is an age-specific survival factor for sensory and autonomic neurons. Neuron 15, 821-828.
67. Pycock, C. J. (1980) Turning behavior in animals. Neuroscience 5, 461-514.
68. Tseng, J. L., Baetge, E. E., Zurn, A. D. and Aebischer, P. (1997) GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine. J. Neurosci. 17, 325-333.
69. Schwarting, R. K. and Huston, J. P. (1996) The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog. Neurobiol. 50, 275-331.
70. Bowenkamp, K. E., Hoffman, A. F., Gerhardt, G. A., Henry, M. A., Biddle, P. T., Hoffer, B. J. and Granholm, A. C. E. (1995) Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J. Comp. Neurol. 355, 479-489.
71. Sauer, H. and Oertel, W. H. (1994) Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59, 401-415.
72. Sauer, H., Rosenblad, C. and Bjorklund, A. (1997) Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. Natl. Acad. Sci. USA 92, 8935-8939.
73. Choi-Lundberg, D. L., Lin, Q., Chang, Y. N., Chiang, Y. L., Hay, C. M., Mohajeri, H., Davidson, B. L. and Bohn, M. C. (1997) Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275, 838-841.
74. Schapira, A. H. (1992) MPTP and other Parkinson-inducing agents. Curr. Opin. Neurol. Neurosurg. 5, 396-400.
75. Zhang, Z., Miyoshi, Y., Lapchak, P. A., Collins, F., Hilt, D., Lebel, C., Kryscio, R. and Gash, D. M. (1997) Dose response to intraventricular glial cell line-derived neurotrophic factor administration in parkinsonian monkeys. J. Pharmacol. Exp. Ther. 282, 1396-1401.
76. Matheson, C. R., Wang, J., Collins, F. D. and Yan, Q. (1997) Long-term survival effects of GDNF on neonatal rat facial motoneurons after axotomy. NeuroReport 8, 1739-1742.
77. Gimenez y Ribotta, M., Revah, F., Pradier, L., Loquet, I., Mallet, J. and Privat, A. (1997) Prevention of motoneuron death by adenovirus-mediated neurotrophic factors. J. Neurosci. Res. 48, 281-285.
78. Baumgartner, B. J. and Shine, H. D. (1997) Targeted transduction of CNS neurons with adenoviral vectors carrying neurotrophic factor genes confers neuroprotection that exceeds the transduced population. J. Neurosci. 17, 6504-6511.
79. Schmalbruch, H., Jensen, H. J., Bjaerg, M., Kamieniecka, Z. and Kurland, L. (1991) A new mouse mutant with progressive motor neuronopathy. J. Neuropathol. Exp. Neurol. 50, 192-204.
80. Sendtner, M., Schmalbruch, H., Stockli, K. A., Carroll, P., Kreutzberg, G. W. and Thoenen, H. (1992) Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 358, 502-504.
81. Sagot, Y., Tan, S. A., Hammang, J. P., Aebischer, P. and Kato, A. C. (1996) GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice. J. Neurosci. 16, 2335-2341.
82. Batchelor, P. E., Armstrong, D. M., Blaker, S. N. and Gage, F. H. (1989) Nerve growth factor receptor and choline acetyltransferase colocalization in neurons within the rat forebrain: Response to fimbria-fornix transection. J. Comp. Neurol. 284, 187-204.
83. Sofroniew, M. V., Cooper, J. D., Svendson, C. N., Crossman, P., Ip, N. Y., Lindsay, R. M., Zafra, F. and Lindholm, D. (1993) Atrophy but not death of adult septal cholinergic neurons after ablation of target capacity to produce mRNAs for NGF, BDNF, and NT3. J. Neurosci. 13, 5263-5276.
84. Williams, L. R., Inouye, G., Cummins, V. and Pelleymounter, M. A. (1996) Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: Dose-response comparison to nerve growth factor and brain-derived neurotrophic factor. J. Pharmacol. Exp. Ther. 277, 1140-1151.
85. Houenou, L. J., Oppenheim, R. W., Li, L. X., Lo, A. C. and Prevette, D. (1996) Regulation of spinal motoneuron survival by GDNF during development and following injury. Cell Tissue Res. 286, 219-223.
86. Humpel, C., Hoffer, B., Stromberg, I., Bektesh, S., Collins, F. and Olson, L. (1994) Neurons of the hippocampal formation express glial cell line-derived neurotrophic factor messenger RNA in response to kainate-induced excitation. Neuroscience 59, 791-795.
87. Olson, L., Nordberg, A., vonHolst, H., Backman, L., Ebendal, T., Alafuzoff, I., Amberla, K., Hartvig, P., Herlitz, A., Lilja, A., et al. (1992) Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). J. Neural Transm. Park. Dis. Dement. Sect. 4, 79-95.
88. Olson, L., Backlund, E. O., Ebendal, T., Freedman, R., Hamberger, B., Hansson, P., Hoffer, B., Lindblom, U., Meyerson, B., Stromberg, I., et al. (1991) Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. One-year follow-up of first clinical trial. Arch. Neurol. 48, 373-378.
89. Bilang-Bleuel, A., Revah, F., Colin, P., Locquet, I., Robert, J.J., Mallet, J. and Horellou, P. (1997) Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. Proc. Natl. Acad. Sci. USA 94, 8818-8823.
90. Winkler, C., Sauer, H., Lee, C. S. and Björklund, A. (1996) Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci. 16, 7206-7215.
91. Dore, S., Kar, S., and Quiron, R. (1997) Rediscovering an old friend, IGF-1: potential use in the treatment of neurodegenerative diseases. Trends Neurosci. 20, 326-331.
92. Lai, E. C., Felice, K. J., Festoff, B. W., Gawel, M. J., Gelinas, D. F., Kratz, R., Murphy, M. F., Natter, H. M., Norris, F. H. and Rudnicki, S. A. (1997) Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group. Neurology 49, 1621-1630.
93. Borasio, G. D., Robberecht, W., Leigh, P. N., Emile, J., Guiloff, R. J., Jerusalem, F., Silani, V., Vos, P. E., Wokke, J. H., and Dobbins, T. (1998) A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group. Neurology 51, 583-586.
94. ALS CNTF Treatment Study Group (1996) A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. Neurology 46, 1244-1249.
95. GFRα Nomenclature Committee (1997) Nomenclature of GPI-linked receptors for the GDNF ligand family. Neuron 19, 485.